Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy
出版年份 2016 全文链接
标题
Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy
作者
关键词
-
出版物
JOURNAL OF SURGICAL ONCOLOGY
Volume 113, Issue 4, Pages 443-448
出版商
Wiley
发表日期
2016-04-10
DOI
10.1002/jso.24141
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver
- (2015) Julius Chapiro et al. EUROPEAN RADIOLOGY
- Comparison of RECIST 1.0 and RECIST 1.1 in Patients with Metastatic Cancer: A Pooled Analysis
- (2015) Jung Han Kim et al. Journal of Cancer
- Comparison of RECIST 1.0 and RECIST 1.1 on Computed Tomography in Patients with Metastatic Colorectal Cancer
- (2014) H.J. Jang et al. ONCOLOGY
- Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI®) for colorectal liver metastases does not predict tumour destruction or long-term outcome
- (2013) R.P. Jones et al. EJSO
- Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
- (2013) Eun Suk Jung et al. JOURNAL OF HEPATOLOGY
- Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor
- (2013) Michael E. Egger et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
- (2012) H. J. Prajapati et al. ANNALS OF ONCOLOGY
- Why RECIST Works and Why It Should Stay--Reply to Counterpoint
- (2012) M. R. Sharma et al. CANCER RESEARCH
- RECIST: No Longer the Sharpest Tool in the Oncology Clinical Trials Toolbox--Point
- (2012) M. R. Sharma et al. CANCER RESEARCH
- Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
- (2012) Beom Kyung Kim et al. EUROPEAN JOURNAL OF CANCER
- Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times
- (2011) Khairuddin Memon et al. GASTROENTEROLOGY
- EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
- (2011) Roopinder Gillmore et al. JOURNAL OF HEPATOLOGY
- Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models
- (2011) Ju Hyun Shim et al. RADIOLOGY
- Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study
- (2010) Robert C. G. Martin et al. ANNALS OF SURGICAL ONCOLOGY
- Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma
- (2009) Alejandro Forner et al. CANCER
- Is Selective Internal Radioembolization Safe and Effective for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis?
- (2009) Charles E. Woodall et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started